Scott Harkonen
Impact in
- Nephrology top 5%
- Acute Kidney Injury Research
-
- Toxin Mechanisms and Immunotoxins
- Immune Cell Function and Interaction
Papers in
-
- Toxin Mechanisms and Immunotoxins 2
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Carl M. Kjellstrand (3 shared papers)R P Mischak (3 shared papers)Patrick J. Scannon (2 shared papers)Lynn E. S̄pitler (2 shared papers)John W. Torseth (2 shared papers)Terrence F. Blaschke (2 shared papers)T. C. Merigan (2 shared papers)Michael Skinner (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (2 papers)American Journal of Nephrology (1 paper)The Nephron journals/Nephron journals (1 paper)The Journal of Infectious Diseases (1 paper)The American Journal of Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Scott Harkonen
11 papers receiving 341 citations
Peers
Comparison fields: 5 of 63
- Nephrology 91
- Immunology 94
- Hematology 44
- Critical Care and Intensive Care Medicine 16
- Infectious Diseases 59
Countries citing papers authored by Scott Harkonen
This map shows the geographic impact of Scott Harkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Harkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Harkonen more than expected).
Fields of papers citing papers by Scott Harkonen
This network shows the impact of papers produced by Scott Harkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Harkonen. The network helps show where Scott Harkonen may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott Harkonen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1977 | 123 | |
| 2 | 1989 | 72 | |
| 3 | 1990 | 48 | |
| 4 | 1988 | 47 | |
| 5 | Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats. | 1987 | 34 |
| 6 | 1996 | 22 | |
| 7 | 2008 | 16 | |
| 8 | 1989 | 11 | |
| 9 | 1995 | 11 | |
| 10 | 1987 | 6 | |
| 11 | 2008 | 3 |
About Scott Harkonen
Scott Harkonen is a scholar working on Immunology, Infectious Diseases, Molecular Biology, Endocrinology, Diabetes and Metabolism and Biotechnology, having authored 11 papers that have together received 393 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Transgenic Plants and Applications (2 papers), Neurological and metabolic disorders (2 papers), Microbial Inactivation Methods (1 paper), Neurological Complications and Syndromes (1 paper), Streptococcal Infections and Treatments (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Nephrology (91 citations), Immunology (94 citations), Hematology (44 citations), Critical Care and Intensive Care Medicine (16 citations) and Infectious Diseases (59 citations). Scott Harkonen has collaborated with scholars based in United States. Frequent co-authors include Carl M. Kjellstrand, R P Mischak, Patrick J. Scannon, Lynn E. S̄pitler, John W. Torseth, Terrence F. Blaschke, T. C. Merigan, Michael Skinner, D.H. Kennedy and Richard N. Greenberg. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, American Journal of Nephrology, The Nephron journals/Nephron journals, The Journal of Infectious Diseases and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.